Loading…

Investigation of Potential Anticarcinogenic Effects of Corilagin in Lung Cancer Cells

Objective: Lung cancer (LC) is the most extensive reason of cancer associated deaths in men and women in the world. LC categorizes into two main groups due to their molecular clinicopathological features and therapeutic responses. Non-small cell lung cancer (NSCLC) is the main subgroup that consists...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and experimental health sciences (Online) 2019-09, Vol.9 (3), p.228-231
Main Authors: RENCUZOGULLARİ, Cagla, CİNCİN, Zeynep Birsu, IPLİK, Elif Sinem, BARAN, Yusuf, CAKMAKOGLU, Bedia
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c334t-e1eefa471347caa68cea4537372a8cea844c33e40f0269e4a8abcfec74e5bb923
cites cdi_FETCH-LOGICAL-c334t-e1eefa471347caa68cea4537372a8cea844c33e40f0269e4a8abcfec74e5bb923
container_end_page 231
container_issue 3
container_start_page 228
container_title Clinical and experimental health sciences (Online)
container_volume 9
creator RENCUZOGULLARİ, Cagla
CİNCİN, Zeynep Birsu
IPLİK, Elif Sinem
BARAN, Yusuf
CAKMAKOGLU, Bedia
description Objective: Lung cancer (LC) is the most extensive reason of cancer associated deaths in men and women in the world. LC categorizes into two main groups due to their molecular clinicopathological features and therapeutic responses. Non-small cell lung cancer (NSCLC) is the main subgroup that consists of nearly 85% of all lung cancer types. Corilagin, a biologically active ellagitannin, could be extracted from Phyllanthus species which are known as Chinese medicinal plant. It has been recently shown that Corilagin could exert anti-inflammatuar and antioxidative effects in different experimental cancer models. However, the molecular effects of Corilagin in NSCLC remain unclear.Methods: In this study, the antiproliferative and apoptotic effects of Corilagin were identified by caspase-3 molecule and loss of mitochondrial membrane potential (MMP).Results: We found that Corilagin significiantly suppressed the proliferation of NSCLC cells. Furthermore, we also showed that Corilagin could contribute apoprosis by inducing activity of caspase-3 molecule and loss of MMP.Conclusion: Taken together, our study first showed that Corilagin could be a new treatment method for NSCLC after verifying its effects with in vivo and clinical studies.
doi_str_mv 10.33808/clinexphealthsci.599707
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2719094361</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2719094361</sourcerecordid><originalsourceid>FETCH-LOGICAL-c334t-e1eefa471347caa68cea4537372a8cea844c33e40f0269e4a8abcfec74e5bb923</originalsourceid><addsrcrecordid>eNpdkEtLAzEUhYMoWGr_Q8D11GSSaSbLMtQHFHRh18NtuDNNiUlNUtF_b2pdiHC55yw-7uMQQjmbC9Gy9s446_HzsENweZeMnTdaK6YuyKSWja54aZd__DWZpbRnjNW1FEy0E7J58h-Ysh0h2-BpGOhLyOizBUeXRQxEY30Y0VtDV8OAJqcT1YVoHYzW01Lrox9pB95gpB06l27I1QAu4exXp2Rzv3rtHqv188NTt1xXRgiZK-SIA0jFhVQGYNEaBNkIJVQNJ99KWUCUbGD1QqOEFramnKAkNtutrsWU3J7nHmJ4P5Y_-n04Rl9W9rXimmkpFrxQ7ZkyMaQUcegP0b5B_Oo5639y7P_n2J9zFN_qb2ze</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2719094361</pqid></control><display><type>article</type><title>Investigation of Potential Anticarcinogenic Effects of Corilagin in Lung Cancer Cells</title><source>Publicly Available Content Database</source><creator>RENCUZOGULLARİ, Cagla ; CİNCİN, Zeynep Birsu ; IPLİK, Elif Sinem ; BARAN, Yusuf ; CAKMAKOGLU, Bedia</creator><creatorcontrib>RENCUZOGULLARİ, Cagla ; CİNCİN, Zeynep Birsu ; IPLİK, Elif Sinem ; BARAN, Yusuf ; CAKMAKOGLU, Bedia</creatorcontrib><description>Objective: Lung cancer (LC) is the most extensive reason of cancer associated deaths in men and women in the world. LC categorizes into two main groups due to their molecular clinicopathological features and therapeutic responses. Non-small cell lung cancer (NSCLC) is the main subgroup that consists of nearly 85% of all lung cancer types. Corilagin, a biologically active ellagitannin, could be extracted from Phyllanthus species which are known as Chinese medicinal plant. It has been recently shown that Corilagin could exert anti-inflammatuar and antioxidative effects in different experimental cancer models. However, the molecular effects of Corilagin in NSCLC remain unclear.Methods: In this study, the antiproliferative and apoptotic effects of Corilagin were identified by caspase-3 molecule and loss of mitochondrial membrane potential (MMP).Results: We found that Corilagin significiantly suppressed the proliferation of NSCLC cells. Furthermore, we also showed that Corilagin could contribute apoprosis by inducing activity of caspase-3 molecule and loss of MMP.Conclusion: Taken together, our study first showed that Corilagin could be a new treatment method for NSCLC after verifying its effects with in vivo and clinical studies.</description><identifier>ISSN: 2459-1459</identifier><identifier>EISSN: 2459-1459</identifier><identifier>DOI: 10.33808/clinexphealthsci.599707</identifier><language>eng</language><publisher>Istanbul: Marmara University</publisher><subject>Lung cancer</subject><ispartof>Clinical and experimental health sciences (Online), 2019-09, Vol.9 (3), p.228-231</ispartof><rights>2019. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://dergipark.org.tr/en/pub/clinexphealthsci/about-journal</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c334t-e1eefa471347caa68cea4537372a8cea844c33e40f0269e4a8abcfec74e5bb923</citedby><cites>FETCH-LOGICAL-c334t-e1eefa471347caa68cea4537372a8cea844c33e40f0269e4a8abcfec74e5bb923</cites><orcidid>0000-0002-1056-4673 ; 0000-0003-4113-6820 ; 0000-0003-3465-1808 ; 0000-0001-7960-9131 ; 0000-0001-6948-5382</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2719094361?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25753,27924,27925,37012,44590</link.rule.ids></links><search><creatorcontrib>RENCUZOGULLARİ, Cagla</creatorcontrib><creatorcontrib>CİNCİN, Zeynep Birsu</creatorcontrib><creatorcontrib>IPLİK, Elif Sinem</creatorcontrib><creatorcontrib>BARAN, Yusuf</creatorcontrib><creatorcontrib>CAKMAKOGLU, Bedia</creatorcontrib><title>Investigation of Potential Anticarcinogenic Effects of Corilagin in Lung Cancer Cells</title><title>Clinical and experimental health sciences (Online)</title><description>Objective: Lung cancer (LC) is the most extensive reason of cancer associated deaths in men and women in the world. LC categorizes into two main groups due to their molecular clinicopathological features and therapeutic responses. Non-small cell lung cancer (NSCLC) is the main subgroup that consists of nearly 85% of all lung cancer types. Corilagin, a biologically active ellagitannin, could be extracted from Phyllanthus species which are known as Chinese medicinal plant. It has been recently shown that Corilagin could exert anti-inflammatuar and antioxidative effects in different experimental cancer models. However, the molecular effects of Corilagin in NSCLC remain unclear.Methods: In this study, the antiproliferative and apoptotic effects of Corilagin were identified by caspase-3 molecule and loss of mitochondrial membrane potential (MMP).Results: We found that Corilagin significiantly suppressed the proliferation of NSCLC cells. Furthermore, we also showed that Corilagin could contribute apoprosis by inducing activity of caspase-3 molecule and loss of MMP.Conclusion: Taken together, our study first showed that Corilagin could be a new treatment method for NSCLC after verifying its effects with in vivo and clinical studies.</description><subject>Lung cancer</subject><issn>2459-1459</issn><issn>2459-1459</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkEtLAzEUhYMoWGr_Q8D11GSSaSbLMtQHFHRh18NtuDNNiUlNUtF_b2pdiHC55yw-7uMQQjmbC9Gy9s446_HzsENweZeMnTdaK6YuyKSWja54aZd__DWZpbRnjNW1FEy0E7J58h-Ysh0h2-BpGOhLyOizBUeXRQxEY30Y0VtDV8OAJqcT1YVoHYzW01Lrox9pB95gpB06l27I1QAu4exXp2Rzv3rtHqv188NTt1xXRgiZK-SIA0jFhVQGYNEaBNkIJVQNJ99KWUCUbGD1QqOEFramnKAkNtutrsWU3J7nHmJ4P5Y_-n04Rl9W9rXimmkpFrxQ7ZkyMaQUcegP0b5B_Oo5639y7P_n2J9zFN_qb2ze</recordid><startdate>20190901</startdate><enddate>20190901</enddate><creator>RENCUZOGULLARİ, Cagla</creator><creator>CİNCİN, Zeynep Birsu</creator><creator>IPLİK, Elif Sinem</creator><creator>BARAN, Yusuf</creator><creator>CAKMAKOGLU, Bedia</creator><general>Marmara University</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>EDSIH</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><orcidid>https://orcid.org/0000-0002-1056-4673</orcidid><orcidid>https://orcid.org/0000-0003-4113-6820</orcidid><orcidid>https://orcid.org/0000-0003-3465-1808</orcidid><orcidid>https://orcid.org/0000-0001-7960-9131</orcidid><orcidid>https://orcid.org/0000-0001-6948-5382</orcidid></search><sort><creationdate>20190901</creationdate><title>Investigation of Potential Anticarcinogenic Effects of Corilagin in Lung Cancer Cells</title><author>RENCUZOGULLARİ, Cagla ; CİNCİN, Zeynep Birsu ; IPLİK, Elif Sinem ; BARAN, Yusuf ; CAKMAKOGLU, Bedia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c334t-e1eefa471347caa68cea4537372a8cea844c33e40f0269e4a8abcfec74e5bb923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Lung cancer</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>RENCUZOGULLARİ, Cagla</creatorcontrib><creatorcontrib>CİNCİN, Zeynep Birsu</creatorcontrib><creatorcontrib>IPLİK, Elif Sinem</creatorcontrib><creatorcontrib>BARAN, Yusuf</creatorcontrib><creatorcontrib>CAKMAKOGLU, Bedia</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Turkey Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Clinical and experimental health sciences (Online)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>RENCUZOGULLARİ, Cagla</au><au>CİNCİN, Zeynep Birsu</au><au>IPLİK, Elif Sinem</au><au>BARAN, Yusuf</au><au>CAKMAKOGLU, Bedia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Investigation of Potential Anticarcinogenic Effects of Corilagin in Lung Cancer Cells</atitle><jtitle>Clinical and experimental health sciences (Online)</jtitle><date>2019-09-01</date><risdate>2019</risdate><volume>9</volume><issue>3</issue><spage>228</spage><epage>231</epage><pages>228-231</pages><issn>2459-1459</issn><eissn>2459-1459</eissn><abstract>Objective: Lung cancer (LC) is the most extensive reason of cancer associated deaths in men and women in the world. LC categorizes into two main groups due to their molecular clinicopathological features and therapeutic responses. Non-small cell lung cancer (NSCLC) is the main subgroup that consists of nearly 85% of all lung cancer types. Corilagin, a biologically active ellagitannin, could be extracted from Phyllanthus species which are known as Chinese medicinal plant. It has been recently shown that Corilagin could exert anti-inflammatuar and antioxidative effects in different experimental cancer models. However, the molecular effects of Corilagin in NSCLC remain unclear.Methods: In this study, the antiproliferative and apoptotic effects of Corilagin were identified by caspase-3 molecule and loss of mitochondrial membrane potential (MMP).Results: We found that Corilagin significiantly suppressed the proliferation of NSCLC cells. Furthermore, we also showed that Corilagin could contribute apoprosis by inducing activity of caspase-3 molecule and loss of MMP.Conclusion: Taken together, our study first showed that Corilagin could be a new treatment method for NSCLC after verifying its effects with in vivo and clinical studies.</abstract><cop>Istanbul</cop><pub>Marmara University</pub><doi>10.33808/clinexphealthsci.599707</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-1056-4673</orcidid><orcidid>https://orcid.org/0000-0003-4113-6820</orcidid><orcidid>https://orcid.org/0000-0003-3465-1808</orcidid><orcidid>https://orcid.org/0000-0001-7960-9131</orcidid><orcidid>https://orcid.org/0000-0001-6948-5382</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2459-1459
ispartof Clinical and experimental health sciences (Online), 2019-09, Vol.9 (3), p.228-231
issn 2459-1459
2459-1459
language eng
recordid cdi_proquest_journals_2719094361
source Publicly Available Content Database
subjects Lung cancer
title Investigation of Potential Anticarcinogenic Effects of Corilagin in Lung Cancer Cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T20%3A18%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Investigation%20of%20Potential%20Anticarcinogenic%20Effects%20of%20Corilagin%20in%20Lung%20Cancer%20Cells&rft.jtitle=Clinical%20and%20experimental%20health%20sciences%20(Online)&rft.au=RENCUZOGULLAR%C4%B0,%20Cagla&rft.date=2019-09-01&rft.volume=9&rft.issue=3&rft.spage=228&rft.epage=231&rft.pages=228-231&rft.issn=2459-1459&rft.eissn=2459-1459&rft_id=info:doi/10.33808/clinexphealthsci.599707&rft_dat=%3Cproquest_cross%3E2719094361%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c334t-e1eefa471347caa68cea4537372a8cea844c33e40f0269e4a8abcfec74e5bb923%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2719094361&rft_id=info:pmid/&rfr_iscdi=true